Gately; Stephen T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gately; Stephen T..The latest application filed is for "autophagy inhibitors".

Company Profile

1.11.12

Gately; Stephen T. - Scottsdale AZ
Gately; Stephen T. - Palatine IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Autophagy inhibitors Grant 10,544,100 - MacKeigan , et al. Ja	2020-01-28
Autophagy Inhibitors App 20180290980 - MacKeigan; Jeffrey Paul ; et al.	2018-10-11
Therapeutic combination for cancer treatment Grant 9,532,984 - Gately January 3, 2	2017-01-03
Solid forms of curcumin Grant 9,447,050 - Gately , et al. September 20, 2	2016-09-20
Autophagy Inhibitors App 20160137607 - MacKeigan; Jeffrey Paul ; et al.	2016-05-19
Therapeutic Combination For Cancer Treatment App 20140113930 - Gately; Stephen T.	2014-04-24
Solid Forms of Curcumin App 20140031403 - Gately; Stephen T. ; et al.	2014-01-30
IL 13 receptor alpha 2 antibody and methods of use App 20060099652 - Gately; Stephen T. ; et al.	2006-05-11
Methods and compositions for generating angiostatin App 20060099671 - Soff; Gerald ; et al.	2006-05-11
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent Grant 6,916,800 - McKearn , et al. July 12, 2	2005-07-12
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent App 20050058725 - McKearn, John P. ; et al.	2005-03-17
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Grant 6,858,598 - McKearn , et al. February 22, 2	2005-02-22
Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent App 20050037090 - McKearn, John P. ; et al.	2005-02-17
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Grant 6,833,373 - McKearn , et al. December 21, 2	2004-12-21
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia App 20040234624 - McKearn, John P. ; et al.	2004-11-25
Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia Grant 6,689,787 - McKearn , et al. February 10, 2	2004-02-10
Methods and compositions for generating angiostatin Grant 6,576,609 - Soff , et al. June 10, 2	2003-06-10
Antiangiogenic combination therapy for the treatment of cancer App 20020103141 - McKearn, John P. ; et al.	2002-08-01
Methods and compositions for generating angiostatin Grant 5,801,012 - Soff , et al. September 1, 1	1998-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.